Your browser doesn't support javascript.
loading
Compressive stress-mediated p38 activation required for ERα + phenotype in breast cancer.
Munne, Pauliina M; Martikainen, Lahja; Räty, Iiris; Bertula, Kia; Ruuska, Janika; Ala-Hongisto, Hanna; Peura, Aino; Hollmann, Babette; Euro, Lilya; Yavuz, Kerim; Patrikainen, Linda; Salmela, Maria; Pokki, Juho; Kivento, Mikko; Väänänen, Juho; Suomi, Tomi; Nevalaita, Liina; Mutka, Minna; Kovanen, Panu; Leidenius, Marjut; Meretoja, Tuomo; Hukkinen, Katja; Monni, Outi; Pouwels, Jeroen; Sahu, Biswajyoti; Mattson, Johanna; Joensuu, Heikki; Heikkilä, Päivi; Elo, Laura L; Metcalfe, Ciara; Junttila, Melissa R; Ikkala, Olli; Klefström, Juha.
Affiliation
  • Munne PM; Finnish Cancer Institute, FICAN South Helsinki University Hospital & Translational Cancer Medicine, Medical Faculty, University of Helsinki. Cancer Cell Circuitry Laboratory, PO Box 63 Haartmaninkatu 8, 00014 University of Helsinki, Helsinki, Finland.
  • Martikainen L; Department of Applied Physics, Molecular Materials Group, Aalto University School of Science, PO Box, 15100, FI-00076, Espoo, Finland.
  • Räty I; Finnish Cancer Institute, FICAN South Helsinki University Hospital & Translational Cancer Medicine, Medical Faculty, University of Helsinki. Cancer Cell Circuitry Laboratory, PO Box 63 Haartmaninkatu 8, 00014 University of Helsinki, Helsinki, Finland.
  • Bertula K; Department of Applied Physics, Molecular Materials Group, Aalto University School of Science, PO Box, 15100, FI-00076, Espoo, Finland.
  • Nonappa; Department of Applied Physics, Molecular Materials Group, Aalto University School of Science, PO Box, 15100, FI-00076, Espoo, Finland.
  • Ruuska J; Department of Bioproducts and Biosystems, Aalto University School of Chemical Engineering, Espoo, Finland.
  • Ala-Hongisto H; Finnish Cancer Institute, FICAN South Helsinki University Hospital & Translational Cancer Medicine, Medical Faculty, University of Helsinki. Cancer Cell Circuitry Laboratory, PO Box 63 Haartmaninkatu 8, 00014 University of Helsinki, Helsinki, Finland.
  • Peura A; Finnish Cancer Institute, FICAN South Helsinki University Hospital & Translational Cancer Medicine, Medical Faculty, University of Helsinki. Cancer Cell Circuitry Laboratory, PO Box 63 Haartmaninkatu 8, 00014 University of Helsinki, Helsinki, Finland.
  • Hollmann B; Finnish Cancer Institute, FICAN South Helsinki University Hospital & Translational Cancer Medicine, Medical Faculty, University of Helsinki. Cancer Cell Circuitry Laboratory, PO Box 63 Haartmaninkatu 8, 00014 University of Helsinki, Helsinki, Finland.
  • Euro L; Finnish Cancer Institute, FICAN South Helsinki University Hospital & Translational Cancer Medicine, Medical Faculty, University of Helsinki. Cancer Cell Circuitry Laboratory, PO Box 63 Haartmaninkatu 8, 00014 University of Helsinki, Helsinki, Finland.
  • Yavuz K; Research Program of Stem Cells and Metabolism, Biomedicum Helsinki, University of Helsinki, 00290, Helsinki, Finland.
  • Patrikainen L; Applied Tumor Genomics Research Program, Enhancer Biology Laboratory, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Salmela M; Finnish Cancer Institute, FICAN South Helsinki University Hospital & Translational Cancer Medicine, Medical Faculty, University of Helsinki. Cancer Cell Circuitry Laboratory, PO Box 63 Haartmaninkatu 8, 00014 University of Helsinki, Helsinki, Finland.
  • Pokki J; Finnish Cancer Institute, FICAN South Helsinki University Hospital & Translational Cancer Medicine, Medical Faculty, University of Helsinki. Cancer Cell Circuitry Laboratory, PO Box 63 Haartmaninkatu 8, 00014 University of Helsinki, Helsinki, Finland.
  • Kivento M; Department of Electrical Engineering and Automation, Aalto University, Espoo, Finland.
  • Väänänen J; Applied Tumor Genomics Research Program, Faculty of Medicine, Oncogenomics Laboratory, University of Helsinki, Helsinki, Finland.
  • Suomi T; Applied Tumor Genomics Research Program, Faculty of Medicine, Oncogenomics Laboratory, University of Helsinki, Helsinki, Finland.
  • Nevalaita L; Turku Bioscience Centre, University of Turku and Åbo Akademi University, FI-20520, Turku, Finland.
  • Mutka M; Finnish Cancer Institute, FICAN South Helsinki University Hospital & Translational Cancer Medicine, Medical Faculty, University of Helsinki. Cancer Cell Circuitry Laboratory, PO Box 63 Haartmaninkatu 8, 00014 University of Helsinki, Helsinki, Finland.
  • Kovanen P; Department of Pathology, HUSLAB and Haartman Institute, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland.
  • Leidenius M; Department of Pathology, HUSLAB and Haartman Institute, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland.
  • Meretoja T; Breast Surgery Unit, Helsinki University Central Hospital, Helsinki, Finland.
  • Hukkinen K; Breast Surgery Unit, Helsinki University Central Hospital, Helsinki, Finland.
  • Monni O; Department of Mammography, Helsinki University Central Hospital, Helsinki, Finland.
  • Pouwels J; Applied Tumor Genomics Research Program, Faculty of Medicine, Oncogenomics Laboratory, University of Helsinki, Helsinki, Finland.
  • Sahu B; Finnish Cancer Institute, FICAN South Helsinki University Hospital & Translational Cancer Medicine, Medical Faculty, University of Helsinki. Cancer Cell Circuitry Laboratory, PO Box 63 Haartmaninkatu 8, 00014 University of Helsinki, Helsinki, Finland.
  • Mattson J; Applied Tumor Genomics Research Program, Enhancer Biology Laboratory, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Joensuu H; Department of Oncology, University of Helsinki & Helsinki University Hospital, Helsinki, Finland.
  • Heikkilä P; Department of Oncology, University of Helsinki & Helsinki University Hospital, Helsinki, Finland.
  • Elo LL; Department of Pathology, HUSLAB and Haartman Institute, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland.
  • Metcalfe C; Turku Bioscience Centre, University of Turku and Åbo Akademi University, FI-20520, Turku, Finland.
  • Junttila MR; Genentech Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
  • Ikkala O; Genentech Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
  • Klefström J; Department of Applied Physics, Molecular Materials Group, Aalto University School of Science, PO Box, 15100, FI-00076, Espoo, Finland.
Nat Commun ; 12(1): 6967, 2021 11 29.
Article de En | MEDLINE | ID: mdl-34845227

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein / Mécanotransduction cellulaire / P38 Mitogen-Activated Protein Kinases / Récepteur alpha des oestrogènes / Transcriptome Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Langue: En Journal: Nat Commun Sujet du journal: BIOLOGIA / CIENCIA Année: 2021 Type de document: Article Pays d'affiliation: Finlande Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein / Mécanotransduction cellulaire / P38 Mitogen-Activated Protein Kinases / Récepteur alpha des oestrogènes / Transcriptome Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Langue: En Journal: Nat Commun Sujet du journal: BIOLOGIA / CIENCIA Année: 2021 Type de document: Article Pays d'affiliation: Finlande Pays de publication: Royaume-Uni